Karim Maloum

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report.

A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report.

Journal: OncoTargets and therapy

Published: March 13, 2026

Hyposplenism in systemic lupus erythematosus: biological and radiological characteristics and its association with increased risk of infection.

Hyposplenism in systemic lupus erythematosus: biological and radiological characteristics and its association with increased risk of infection.

Journal: RMD open

Published: September 19, 2025

Performance of the Interleukin Score for IntraOcular Lymphoma Diagnosis Score in the Diagnosis of Vitreoretinal Lymphoma in Clinical Practice.

Performance of the Interleukin Score for IntraOcular Lymphoma Diagnosis Score in the Diagnosis of Vitreoretinal Lymphoma in Clinical Practice.

Journal: American journal of ophthalmology

Published: August 24, 2025

REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.

REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.

Journal: Leukemia

Published: June 21, 2025

Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.

Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.

Journal: Leukemia

Published: May 02, 2025

Acute myeloid leukemia with misleading cytology.

Acute myeloid leukemia with misleading cytology.

Journal: International journal of laboratory hematology

Published: October 30, 2023

The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?

The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?

Journal: Biomedicines

Published: July 18, 2023

ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia.

ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia.

Journal: Leukemia

Published: July 11, 2023

Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.

Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.

Journal: British journal of haematology

Published: December 22, 2022

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).

Journal: Haematologica

Published: September 26, 2022

Perls' Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC).

Perls' Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC).

Journal: Diagnostics (Basel, Switzerland)

Published: May 30, 2022

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy.

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy.

Journal: HemaSphere

Published: December 28, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026